| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00702-006-0453-2 |
| P8608 | Fatcat ID | release_z2eaenqxfnc57ldy2nm6o4mzsi |
| P698 | PubMed publication ID | 16755380 |
| P5875 | ResearchGate publication ID | 7028405 |
| P2093 | author name string | L Zecca | |
| M Gallorini | |||
| M R Terreni | |||
| A Albertini | |||
| E Rizzio | |||
| G Pezzoli | |||
| C Bellei | |||
| F A Zucca | |||
| S Giannelli | |||
| P2860 | cites work | Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes | Q22337213 |
| Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure | Q28145614 | ||
| The ferritins: molecular properties, iron storage function and cellular regulation | Q28609366 | ||
| Parkinson's disease: mechanisms and models | Q29547424 | ||
| Iron, brain ageing and neurodegenerative disorders | Q29615656 | ||
| Brain iron pathways and their relevance to Parkinson's disease. | Q33183051 | ||
| Manganese intoxication | Q33898434 | ||
| Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles. | Q33922930 | ||
| MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson's disease: neuroprotective strategies | Q34035725 | ||
| The motor circuit of the human basal ganglia reconsidered. | Q34112533 | ||
| Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome | Q34221538 | ||
| MELANOGENESIS AND EXTRAPYRAMIDAL DISEASES | Q34257742 | ||
| A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains | Q34300345 | ||
| The neuromelanin of human substantia nigra and its interaction with metals | Q34732635 | ||
| An overview of iron metabolism: molecular and cellular criteria for the selection of iron chelators. | Q35100312 | ||
| Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics | Q35571525 | ||
| ??? | Q64786936 | ||
| ??? | Q64821029 | ||
| Neurodegenerative disease and iron storage in the brain | Q35833236 | ||
| The neuromelanin of human substantia nigra: physiological and pathogenic aspects | Q35947281 | ||
| The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging | Q36449196 | ||
| Regional topography within noradrenergic locus coeruleus as revealed by retrograde transport of horseradish peroxidase | Q39567708 | ||
| Effects of putative neurotransmitters on neuronal activity in monkey auditory cortex | Q40308223 | ||
| Disease-specific patterns of locus coeruleus cell loss | Q41102223 | ||
| Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease | Q41346993 | ||
| 1-Methyl-4-phenylpyridinium (MPP+)-induced apoptosis and mitochondrial oxidant generation: role of transferrin-receptor-dependent iron and hydrogen peroxide | Q42166581 | ||
| Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases | Q42438205 | ||
| Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease | Q43624453 | ||
| Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease | Q44386905 | ||
| Neurodegenerative diseases and oxidative stress | Q44805871 | ||
| Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations | Q45302799 | ||
| Iron and other metals in neuromelanin, substantia nigra, and putamen of human brain | Q48164667 | ||
| Noradrenergic mechanisms in age-related cognitive decline | Q48260235 | ||
| A new major projection from locus coeruleus: the main source of noradrenergic nerve terminals in the ventral and dorsal columns of the spinal cord | Q48271925 | ||
| Total and paramagnetic metals in human substantia nigra and its neuromelanin | Q48367595 | ||
| Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin | Q48375850 | ||
| The neuropathologic basis of different clinical subgroups of Parkinson's disease | Q48633612 | ||
| Studies on neuromelanin: II. Melanin in the brainstems of infants and children | Q49159822 | ||
| Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression. | Q53187673 | ||
| Chronic manganese intoxication. | Q53747417 | ||
| The effect of a synthetic neuromelanin on yield of free hydroxyl radicals generated in model systems | Q54170347 | ||
| Image analyser-assisted morphometry of the locus coeruleus in Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis | Q59449573 | ||
| Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain | Q61714016 | ||
| Epidemiology of Parkinson's disease. | Q67401761 | ||
| Autoradiography of [14C]paraquat or [14C]diquat in frogs and mice: accumulation in neuromelanin | Q68101127 | ||
| Interaction of neuromelanin and iron in substantia nigra and other areas of human brain | Q71474499 | ||
| The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease | Q77521369 | ||
| P433 | issue | 6 | |
| P921 | main subject | substantia nigra | Q753278 |
| P304 | page(s) | 757-767 | |
| P577 | publication date | 2006-04-28 | |
| P1433 | published in | Journal of Neural Transmission | Q15750921 |
| P1476 | title | Neuromelanin and iron in human locus coeruleus and substantia nigra during aging: consequences for neuronal vulnerability | |
| P478 | volume | 113 |
| Q46891982 | A reappraisal of Fe(III) adsorption by melanin |
| Q90397447 | Age-related variability in decision-making: Insights from neurochemistry |
| Q38067144 | Brain iron accumulation in aging and neurodegenerative disorders |
| Q48718497 | Contrast mechanisms associated with neuromelanin-MRI. |
| Q39010650 | Does any drug to treat cancer target mTOR and iron hemostasis in neurodegenerative disorders? |
| Q37500982 | Frontopolar cortex and decision-making efficiency: comparing brain activity of experts with different professional background during an exploration-exploitation task. |
| Q24654140 | Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans |
| Q46367140 | GSTpi expression in MPTP-induced dopaminergic neurodegeneration of C57BL/6 mouse midbrain and striatum |
| Q37078480 | Glutathione metabolism and Parkinson's disease |
| Q36292320 | Histologic validation of locus coeruleus MRI contrast in post-mortem tissue. |
| Q36899049 | In vivo mapping of the human locus coeruleus |
| Q61804464 | In vivo visualization of age-related differences in the locus coeruleus |
| Q83774812 | Increased expression of α-synuclein in aged human brain associated with neuromelanin accumulation |
| Q35834043 | Interaction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease |
| Q28391762 | Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease |
| Q31117154 | Iron in chronic brain disorders: imaging and neurotherapeutic implications |
| Q92051615 | Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases |
| Q52592689 | Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's disease. |
| Q34028030 | Neuromelanin magnetic resonance imaging reveals increased dopaminergic neuron activity in the substantia nigra of patients with schizophrenia. |
| Q37468299 | Neuromelanin marks the spot: identifying a locus coeruleus biomarker of cognitive reserve in healthy aging |
| Q38155132 | Neuromelanin of the human substantia nigra: an update |
| Q55387411 | Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson's disease. |
| Q42845212 | Neuromelanin-sensitive magnetic resonance imaging: a promising technique for depicting tissue characteristics containing neuromelanin |
| Q55432445 | On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease. |
| Q26746899 | Parkinson's Disease: The Mitochondria-Iron Link |
| Q55312441 | Parkinson's disease related signal change in the nigrosomes 1-5 and the substantia nigra using T2* weighted 7T MRI. |
| Q92986830 | Quantitative magnetization transfer imaging of the human locus coeruleus |
| Q90296581 | Targeting Iron Dyshomeostasis for Treatment of Neurodegenerative Disorders |
| Q30852753 | The role of iron in brain ageing and neurodegenerative disorders. |
Search more.